Skip to main content
15 March 2026
Last updated: Saturday 14 March 2026

User account anon menu

  • Login
  • Register and subscribe
Home
  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
    • Who We Are
    • Editorial Board
    • Editorial Policy
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us
    • Contact Form
Menu

Breadcrumb

  1. Home
  2. Antibody-drug Conjugates Come To The Fore

Antibody-drug conjugates come to the fore

Wednesday 14 September 2022
Interviewee/Contributor
Victoria English
Organisation
MedNous

---Subscribe to MedNous to access this article---

Antibody Drug Conjugates ADCs
Cancer (Oncology)
Drug discovery
Strategy

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Poolbeg Pharma names drug developer to SAB

Saturday 14 March 2026

Commit Biologics names biotech entrepreneur as CEO

Saturday 14 March 2026

Orexo changes management in strategic shift

Saturday 14 March 2026

New CFO at Beacon Therapeutics

Saturday 14 March 2026

4basebio names new COO and CCO, strengthens commercial team

Saturday 14 March 2026
View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

  • News
  • Industry appointments
  • Events
  • Research directory
  • Subscribe

Footer

  • Privacy policy

© 2026 Evernow Publishing Ltd.

  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
    • Who We Are
    • Editorial Board
    • Editorial Policy
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us
    • Contact Form